LOGIN
Methylprednisolone is more effective than tenoxicam for subacromial impingment
March 2013
Methylprednisolone is more effective than tenoxicam for subacromial impingment
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
A double-blind randomised controlled study comparing subacromial injection of tenoxicam or methylprednisolone in patients with subacromial impingement
J Bone Joint Surg Br. 2010 Jan;92(1):77-82.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
58 patients with subacromial impingement were randomized to determine the efficacy of a subacromial injection of tenoxicam compared to methylprednisolone. Participants were followed-up for 6 weeks regarding functional outcome measures. The results indicated that methylprednisolone injections offered a significantly greater improvement compared to tenoxicam.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.